CENTER OF BIOMEDICAL RESEARCH EXCELLENCE (COBRE)

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 在过去的一年中，COBRE的TNRRC部分包括：1）Kaushal博士的一个重大项目，2）Bapi Pahar博士的一个试点项目，3）Pahar博士的一个重大项目，该项目在试点项目结束时开始。 最后，从COBRE“毕业”的Cristian Apetrei博士和Andrew MacLean继续参与COBRE。 博士Kaushal的项目名为：结核分枝杆菌sigma H及其在结核病免疫病理学中的调节子。 博士Pahar的项目题为：抗原特异性伊加反应在控制SIV/SHIV感染中的重要性。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. During the last year the TNPRC Portion of the COBRE has consisted of 1) a major project to Dr. Kaushal, 2) a pilot project to Dr. Bapi Pahar and 3) a major project to Dr. Pahar that began when his pilot project ended. Lastly, Dr. Cristian Apetrei and Andrew MacLean who "graduated" from the COBRE continue to be involved in the COBRE. Dr. Kaushal's project is entitled: Mycobacterium tuberculosis sigma H and its regulon in the immunopathology of Tuberculosis. Dr. Pahar's project is entitled: Importance of antigen specific IgA responses in controlling SIV/SHIV infection.